RE: All buys19 Dec 2019 11:57
Scruffe. Put it this way the Dermasys in the words of the worlds leading doctor in the ED market is ‘REMARKABLE’. This clearly works very well. You then have to take into consideration it has a highly likely chance of an easy route to market, hassle free for the big pharmas. Bearing this in mind I would say libreum are pretty close with their estimation of 60p but who knows. I didn’t expect I’d be picking up shares at 8.75p-12.5p at this stage in FUMs timeline!!